Literature DB >> 11756579

Octreotide therapy for tumor-induced osteomalacia.

J Seufert1, K Ebert, J Müller, J Eulert, C Hendrich, E Werner, N Schuüze, G Schulz, W Kenn, H Richtmann, K D Palitzsch, F Jakob.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756579     DOI: 10.1056/NEJMoa010839

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

Review 1.  Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.

Authors:  Wouter W de Herder; Steven W J Lamberts
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

Review 2.  Clinical practice: diagnostic approach to the rachitic child.

Authors:  Jaishen Rajah; Kebashni Thandrayen; John M Pettifor
Journal:  Eur J Pediatr       Date:  2011-07-21       Impact factor: 3.183

3.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

4.  Tumor-induced osteomalacia.

Authors:  Mala Kaul; Miriam Silverberg; Edward F Dicarlo; Robert Schneider; Anne R Bass; Doruk Erkan
Journal:  Clin Rheumatol       Date:  2007-01-16       Impact factor: 2.980

Review 5.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 6.  Founders lecture 2007: Metabolic bone disease: what has changed in 30 years?

Authors:  Murali Sundaram
Journal:  Skeletal Radiol       Date:  2009-03-05       Impact factor: 2.199

7.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

Review 8.  [Metabolic bone disease osteomalacia].

Authors:  M A Reuss-Borst
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

Review 9.  [Pathophysiology of bone metabolism].

Authors:  F Jakob; L Seefried; R Ebert
Journal:  Internist (Berl)       Date:  2008-10       Impact factor: 0.743

10.  Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.

Authors:  M Odette Gore; Brian J Welch; Weidong Geng; Wareef Kabbani; Naim M Maalouf; Joseph E Zerwekh; Orson W Moe; Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.